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The phosphoprotein plastin was originally identified as an abundant transformation-induced polypeptide of
chemically transformed neoplastic human fibroblasts. This abundant protein is normally expressed only in
leukocytes, suggesting that it may play a role in hemopoietic cell differentiation. Protein microsequencing of
plastin purified from leukemic T lymphocytes by high-resolution two-dimensional gel electrophoresis produced
eight internal oligopeptide sequences. An oligodeoxynucleotide probe corresponding to one of the oligopeptides
was used to clone cDNAs from transformed human fibroblasts that encoded the seven other oligopeptides
predicted for human plastin. Sequencing and characterization of two cloned cDNAs revealed the existence of
two distinct, but closely related, isoforms of plastin-l-plastin, which is expressed in leukocytes and
transformed fibroblasts, and t-plastin, which is expressed in normal cells of solid tissues and transformed
fibroblasts. The leukocyte isoform I-plastin is expressed in a diverse variety of human tumor cell lines,
suggesting that it may be involved in the neoplastic process of some solid human tumors.
The importance of oncogenes in the development of
human cancer has been amply demonstrated in recent years
by the ability of these genes to cause tumorigenic conversion
of rodent cells. There can be no doubt that other human
genes exist which are not classified as oncogenes per se but
which play important roles in the development and progres-
sion of cancer. One category of these genes encodes abun-
dant structural proteins such as the actins and tropomyosins.
The involvement of these abundant proteins in the neoplastic
transformation process is suggested by the well-documented
observations that isoforms within these structural protein
families are consistently modulated in the transformation of
avian (16, 38), rodent (6, 9, 19, 28), and human (19, 21, 23,
24) cells. This second category of cancer-related genes is set
apart from the so-called oncogenes because modulation of
these genes in a transformation-sensitive manner is likely to
result from regulatory processes activating transcription or
translation rather than from direct activation through muta-
tional processes (5, 36).
Previously, we examined the abundant proteins synthe-
sized in normal and transformed human fibroblasts by means
of comparative high-resolution two-dimensional (2-D) poly-
acrylamide gel electrophoresis and identified an abundant
phosphorylated polypeptide, plastin (p219/p220 [20]; Mr,
68,000; pl 5.3), that is frequently expressed in human cancer
cells of solid tissue but that is not expressed in normal
human fibroblasts (13, 14, 20, 22, 23). When we examined
proteins of normal peripheral blood leukocytes, we found
that the same protein was one of the most abundant consti-
tutively expressed proteins of leukocytes (13). Cross identi-
fication of plastin in the transformed fibroblasts and leuko-
cytes was based upon the finding that the protein identified
as plastin in mixed proteins of the two cell types comigrated
in a 2-D gel as a single spot. Furthermore, two separate
peptide antibodies specific for the amino acid sequence
around residue 244 of actin cross-reacted with plastin from
either transformed fibroblasts or lymphocytes in a 2-D gel
Western blot (immunoblot) (37).
Goldman and colleagues (12, 20) observed that plastin
(p301 [12] or p219/p220 [20]) was polymorphic in charge
among 28 individuals whose leukocyte proteins were exam-
ined by 2-D gel electrophoresis. They later referred to this
protein as NIMH4 and NC4 (10, 11). Together we deter-
mined that NIMH4 (or NC4) and I-plastin of fibroblasts were
the same polypeptide (20). Later, Goldstein et al. also
reported that I-plastin was polymorphic in human leukocytes
(13). Independently, Kondo and Hamaguchi (18) used the
polymorphic character of plastin (LCP1, NIMH4, NC4, or
p219/p220) in a gene segregation analysis to link the I-plastin
gene to the esterase D and retinoblastoma loci on human
chromosome 13. This linkage of the plastin gene to the
esterase D gene has been supported in a separate gene
segregation study by Goldman (David Goldman, National
Institute of Alcohol and Drug Abuse, Bethesda, Md., per-
sonal communication). Despite the reproducible identifica-
tion of plastin and these studies of its expression and
polymorphic character, nothing was known of its molecular
identity.
To study the cellular function of plastin and the mecha-
nisms controlling plastin gene expression, we attempted to
clone the cDNA of the plastin mRNA. By the use of a
degenerate oligonucleotide probe derived from an internal
protein sequence of plastin directly isolated from analytical
2-D electrophoretic gels, we have identified two different,
but highly related, cDNA clones of plastin mRNA. Our main
conclusions are the following: (1) there exist at least two
isoforms of plastin, I-plastin and t-plastin; (ii) the expression
of I-plastin and t-plastin is regulated in a tissue-specific
manner; and (iii) I-plastin is a marker protein for transformed
cells of fibroblasts and some cells of epithelial or endothelial
origin.
MATERIALS AND METHODS
Methods for growing cells for the preparation of cellular
RNA, genomic DNA, and protein extracts and the proce-* Corresponding author.
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dure for 2-D gel electrophoresis have been described in
detail previously (22, 23, 25). Silver staining of proteins in a
gel was done by the procedure of Merril et al. (30).
Protein sequencing. Protein sequencing methods have
been described previously (1-3, 17). In brief, cellular pro-
teins were separated by 2-D gel electrophoresis and trans-
ferred to nitrocellulose paper, each protein spot of interest
was cut out and digested by trypsin, and the resulting
peptides were separated by narrow-bore, reverse-phase
high-pressure liquid chromatography and sequenced in a gas
phase sequenator.
Screening of cDNA library. A AgtlO cDNA library con-
structed from HuT-14 poly(A)+ RNA has been described
previously (25). A probe containing eightfold degenerate
20-mer oligodeoxynucleotides (see Results) was end labeled
with 32P and used to screen this library. The screening
procedures were essentially the same as previously de-
scribed (25), except the hybridization temperature was low-
ered to 37°C and washing was less stringent with a higher salt
concentration (4x SSC [lx SSC is 0.15 M NaCl plus 0.015
M sodium citrate, pH 7]).
Northern (RNA) analysis. Total cellular RNA was pre-
pared by the guanidine hydrochloride method as described
previously (15). Approximately 5 ,ug of each RNA was size
fractionated in a 1% agarose gel containing 50 mM MOPS
(morpholinepropanesulfonic acid) buffer (pH 7), 1 mM
EDTA, and 2.2 M formaldehyde, transferred to nitrocellu-
lose paper, and hybridized to 32P-labeled probes. Hybridiza-
tion proceeded overnight at 65°C in a solution containing 4 x
SSC, 5 x Denhardt solution (8), 50 mM phosphate buffer (pH
7), 10% (wt/vol) dextran sulfate, and 2 x 106 cpm of probe
per ml. Washing was carried out twice in 1 x SSC-0. 1% (wt/
vol) sodium dodecyl sulfate at room temperature for 5 min
each and twice in 0.5x SSC-0.1% sodium dodecyl sulfate at
65°C for 30 min each.
Genomic analysis. Genomic DNA was prepared as de-
scribed by Maniatis et al. (26, 27). Approximately 10 ,ug of
each DNA was digested with Hindlll to completion, elec-
trophoresed on a 0.7% agarose gel, and transferred to
nitrocellulose paper by the method described by Southern
(35). Hybridization and washing of the nitrocellulose paper
were the same as described above.
DNA sequencing. DNA was cloned into M13mp9 (31).
Progressive deletion clones were prepared by the method
described by Dale et al. (7) and sequenced by the method
described by Sanger et al. (34). Sequence information was
managed by Bionet of Intelligenetics Inc., Palo Alto, Calif.
In vitro message selection-translation. To confirm the iden-
tity of a cDNA, in vitro message selection-translation was
used. We have described this methodology in detail previ-
ously (25). In brief, cDNA was bound to nitrocellulose paper
and hybridized with poly(A)+ RNA, hybridized RNA was
recovered and translated in a rabbit reticulocyte system, and
the translational product was separated by 2-D gel electro-
phoresis and visualized by autoradiography.
RESULTS
Evidence for two isoforms. We initially attempted a differ-
ential hybridization approach, using two probes derived
from mRNAs of diploid ("plastin-negative") KD fibroblast
cells and transformed ("plastin-positive") HuT-14 fibroblast
cells, to screen cDNA libraries constructed from poly(A)+
RNAs of human HuT-14 fibrosarcoma cells (23) and human
T-lymphocyte cells (purchased from Clontech, Inc.). De-
spite repeated screening of these libraries and analysis of
potential clones, we were unable to find a clone that would
hybridize to only RNAs of "plastin-positive" cells.
As an alternative approach, we applied two new isolation
techniques which we had developed for protein microse-
quencing (1-3) that enabled us to obtain sequence informa-
tion for proteins purified from 2-D gels. For N-terminal
sequence analysis, proteins were electroblotted from analyt-
ical 2-D gels onto chemically modified glass fiber filter paper
and detected by fluorescent staining. Plastin spots were cut
out and inserted into the sequenator cartridge for direct
sequence analysis (1, 3). In repeated attempts we were
unable to obtain an N-terminal sequence from T-lymphocyte
plastin, although proteins expressed at comparable levels
and simultaneously isolated from the same 2-D gels could
readily be sequenced (1). This suggested that plastin was
blocked at the amino-terminal end. Using our newly devel-
oped procedure (2), we then attempted to obtain internal
protein sequence information of plastin. Proteins in a total
cell lysate of CEM lymphoblastoid cells were separated by
2-D gel electrophoresis and electroblotted onto nitrocellu-
lose. Plastin-containing spots were excised and enzymati-
cally cleaved on the nitrocellulose matrix (2). The resulting
peptides were separated by narrow-bore, reverse-phase
high-pressure liquid chromatography, and individual peptide
fragments were sequenced in a modified Caltech gas phase
sequenator (17). Four peptide sequences that were unambig-
uously identified are listed in Table 1, footnote a.
We synthesized a degenerate oligonucleotide 20-mer cor-
responding to one of the four oligopeptides (Table 1) and
used it to screen a XgtlO cDNA library of transformed
(HuT-14) human fibroblasts (25). From approximately 10,000
recombinants the probe selected a single clone, P4. The
cDNA insert of P4 was 4.3 kilobases (kb) in length. (We later
concluded that this large cDNA was composed of two
unrelated cDNA fragments of 1.0 and 3.3 kb that were
ligated during the construction of the library [data not
shown].) A 2-kb HindlIl fragment within the 3.3-kb cDNA
insert of P4 hybridized to an mRNA of 3.4 kb (Fig. 1A) that
was more abundant in HuT-14 (lane 3) than in normal KD
(lane 2) fibroblasts and not detectable in CEM T lympho-
cytes (lane 1). This result was disappointing since plastin
mRNA should be more abundant in CEM than in HuT-14
and absent in diploid fibroblasts (13). However, when we
sequenced the cDNA, we found four of the oligopeptide
sequences that we had unambiguously identified by direct
amino acid sequence determination (Table 1 and Fig. 2). The
four sequences, peptides 1, 2, 6, and 7, starting at amino acid
residues 85, 132, 458, and 489, respectively, could be unam-
biguously identified. The other four sequences (peptides 3, 4,
5, and 8) were deduced from mixed sequences by using the
completed cDNA sequence.
There were, however, six differences between the protein
sequence (residues 85, 94, 132, 459, 491, and 496) derived
from the lymphocyte plastin protein sequence and the re-
verse-translated cDNA sequence of the cDNA isolated from
transformed fibroblasts (Fig. 2). These differences suggested
that a different, but closely related, cDNA had been cloned.
To identify the protein translation product of the cloned P4
cDNA, we used the entire 4.3-kb cDNA insert to select for
mRNAs by hybridization with poly(A)+ RNA of HuT-14 and
subsequently translated the selected mRNAs in vitro. We
found that the most prominent translation products were two
proteins (t-plastins) migrating to more basic isoelectric
points than the polypeptide recognized as plastin in the 2-D
gel (Fig. 3F and G). These two proteins were synthesized
abundantly in both normal and transformed human fibro-
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TABLE 1. Synthesis of a degenerate oligonucleotide
probe for plastina b
Amino acid Oligopeptide Oligonucleotide Corresponding I-plastin
position sequence probe (antisense)' (senseque)
1 Val C G
A T
CG C
2 Asn T A
T A
AG T
3 Asp C G
T A
AG T
4 Asp C G
T A
AG C
5 Ile T A
A T
I T
6 Ile T A
A T
I T
7 Val C G
A T
a The four unambiguous plastin peptide sequences identified were the
following: (i) . .Glu-Val-Ile-Pro-Met-Asn-Pro-Asn-Ser!or Thr-Asn-Asp-blank-
Phe-blank-Ala-Val...; (ii) ...Thr-Ile-Gln-Glu-Asn-Leu-Asn-Leu-Ala-Leu-Asn-
Ser-Ala-Ser-blank-Ile-Gly...; (iii) ...Val-Asn-Asp-Asp-Ile-Ile-Val-Asn-Tyr-
Val-Asn-Glu...; (iv) ... Ile-Ser-Thr-Ser-Leu-blank-Val-Leu-Asp-Leu-Ile-Asp....
b An eightfold degenerate 20-nucleotide probe was designed from the
I-plastin peptide 3 sequence that exhibited a relatively low degeneracy. This
oligonucleotide was synthesized by using an ABI solid-phase synthesizer. We
preferred to use a relatively short oligonucleotide probe with low degeneracy.
To further minimize degeneracy, we made use of preferred codon usage for
valine and the weak base pair-stabilizing characteristics of inosine (I) in the
isoleucine codon (32).
3' End, ....
blasts (Fig. 3B and C), but were undetectable in leukocytes
(Fig. 3A and E). As these two proteins were apparently
similar to plastin, we decided to use the 2-kb Hindlll
fragment of P4 cDNA as a probe to rescreen the HuT-14
cDNA library in the hope of finding related cDNAs.
Several clones were identified by this rescreening. One of
them, P107, had the largest insert cDNA (3.7 kb) and was
chosen for further examination. In Northern analysis (Fig.
1B), P107 hybridized to an mRNA of 3.7 kb that was more
abundant in CEM lymphocytes (lane 1), less abundant in
transformed HuT-14 fibroblasts (lane 3), and not detectable
in untransformed KD fibroblasts (lane 2). This was the
predicted pattern for I-plastin mRNA expression in these
three cell types (13). Translation of HuT-14 mRNAs selected
by this clone yielded a single polypeptide species that
appeared to be identical to I-plastin in a 2-D gel (Fig. 3H).
We established that this in vitro-synthesized polypeptide
was electrophoretically identical to I-plastin by mixing the in
vitro translation sample in Fig. 3H with labeled unfraction-
ated HuT-12 cellular proteins (23) shown in Fig. 3J. The in
vitro-translated I-plastin, which was in excess of the endog-
enous HuT-12 I-plastin, was superimposed upon the endog-
enous I-plastin after 2-D gel electrophoresis (Fig. 3K). We
therefore concluded that P107 is the true cDNA clone of
A
1 2 3
_.. *S *
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FIG. 1. Northern analysis for cDNA clones. Two identical
Northern blots (A and B) were hybridized with 32P-labeled cDNAs
of P4 (A) and P107 (B), respectively. Each blot contains cellular
RNAs of CEM (lane 1), KD (lane 2), and HuT-14 (lane 3). Size
markers on the right are 28S and 18S rRNAs (5 and 2 kb, respec-
tively.)
I-plastin, whereas P4 cDNA encoded separate polypeptide
isoforms, t-plastins, which closely related to I-plastin.
DNA sequencing of P107 cDNA revealed a coding se-
quence closely related to that of the initially characterized P4
clone (Fig. 2). The P107 cDNA sequence contained the
amino acid residues determined by protein sequence analy-
sis of plastin isolated from CEM lymphocytes in the posi-
tions where discrepancies had existed between the protein
sequence and the P4 cDNA sequence. Each coding sequence
encoded a polypeptide of 570 amino acids with molecular
weight of 64,000. This value is slightly different from our
observed Mr value of I-plastin and the two t-plastin polypep-
tides (Mr- 68,000) in a 2-D gel (13, 23), but is consistent with
the value for I-plastin observed by others (18, 29). Our
predicted amino acid composition obtained for plastin by
computerized microdensitometry was consistent with the
amino acid composition determined from these DNA se-
quences (13).
The existence of two closely related plastin isoforms,
I-plastin of leukocytes and the t-plastins of normal fibro-
blasts, explains why we were unable to identify plastin
cDNA clones through differential hybridization, for the
plastin-negative fibroblast probe contained t-plastin se-
quences that would hybridize to any I-plastin clones. That
I-plastin is expressed in leukocytes and in transformed
fibroblasts (HuT-14) but not in normal fibroblasts is con-
firmed because the oligopeptide sequences were derived
from I-plastin of lymphocytes and the I-plastin cDNA clone
was isolated from transformed HuT-14 fibroblasts. The
t-plastin isoforms, on the other hand, are expressed in both
normal and transformed fibroblasts, but not in leukocytes.
Differential expression of plastin isoforms in human cell
transformation. We surveyed a panel of cultured human cell
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M L D G D R N K D G K I S F D E F V Y I F Q E 23
p4-ATGCTGGATGGTGACAGGAATAAAGATGGGAAAATAAGTTTTGACGAATTTGTTTATATTTTTCAAGAG
p 07-ATGGCTACAGGTGATCTGGACCAAGATGGAAGGATCAGCTTTGATGAGTTTATCAAGATTTTCCATGGC
M A T G D L D Q D G R I S F D E F I K I F H G
V K S S D I A K T F R K A I N R K E G I C A L 46
GTAAAAAGTAGTGATATTGCCAAGACCTTCCGCAAAGCAATCAACAGGAAAGAAGGTATTTGTGCTCTG
CTAAAAAGCACAGATGTTGCCAAGACCTTTAGAAAAGCAATCAATAAGAAGGAAGGGATTTGTGCAATC
L K S T D V A K T F R K A I N K K E G I C A I
G G T S E L S S E G T Q H S Y S E E E K Y A F 69
GGTGGAACTTCAGAGTTGTCCAGCGAAGGAACACAGCATTCTTACTCAGAGGAAGAAAAATATGCTTTT
GGTGGTACTTCAGAGCAGTCTAGCGTTGGCACCCAACACTCCTATTCAGAGGAAGAAAAGTATGCCTTT
G G T S E Q S S V G T Q H S Y S E E E K Y A F
V N W I N K A L E N D P D C R H V I P M N P N 92
GTTAACTGGATAAACAAAGCTTTGGAAAATGATCCTGATTGTAGACATGTTATACCAATGAACCCTAAC
GTCAACTGGATAAACAAAGCCCTGGAAAATGATCCTGATTGTCGGCATGTCATCCCAATGAACCCAAAC
V N W I N K A L E N D P D C R H V I P M N P N
peptide #1 ooE V I P M N P N
T D D L F K A V G D G I V L C K M I N L S V P 115
ACCGATGACCTGTTCAAAGCTGTTGGTGATGGAATTGTGCTTTGTAAAATGATTAACCTTTCAGTTCCT
ACGAATGATCTCTTTAATGCTGTTGGAGATGGCATTGTCCTTTGTAAAATGATCAACCTGTCAGTGCCA
T N D L F N A V G D G I V L C K M I N L S V P
S/T N D - F - A V
D T I D E R A I N K K K L T P F I I Q E N L N 138
GATACCATTGATGAAAGAGCAATCAACAAGAAGAAACTTACACCCTTCATCATTCAGGAAAACTTGAAC
GACACAATTGATGAAAGAACAATCAACAAAAAGAAGCTAACCCCTTTCACCATTCAGGAAAATCTGAAC
D T I D E R T I N K K K L T P F T I Q E N L N
peptide #2-0-T I Q E N L N
L A L N S A S A I G C H V V N I G A E D L R A 161
TTGGCACTGAACTCTGCTTCTGCCATTGGGTGTCATGTTGTGAACATTGGTGCAGAAGATTTGAGGGCT
TTGGCTCTGAACTCTGCCTCAGCCATCGGGTGCCATGTGGTCAACATAGGGGCTGAGGACCTGAAGGAG
L A L N S A S A I G C H V V N I G A E D L K E
L A L N S A S - I G
G K P H L V L G L L W Q I I K I G L F A D I E 184
GGGAAACCTCATCTGGTTTTGGGACTGCTTTGGCAGATCATTAAGATCGGTTTGTTCGCTGACATTGAA
GGGAAGCCTTATCTGGTCCTGGGACTTCTGTGGCAAGTCATCAAGATTGGGTTGTTTGCTGACATTGAA
G K P Y L V L G L L W Q V I K I G L F A D I E
peptide #3-_ A D I E
FIG. 2. Coding sequences and deduced amino acid sequences of P4 cDNA (top) and P107 cDNA (bottom). Identical nucleotides between
the two sequences are indicated by double dots. The eight oligopeptide sequences determined by microsequencing of plastin polypeptide are
indicated.
strains by Northern analysis for I-plastin (Fig. 4A) and more than 50 additional diploid human fibroblast strains
t-plastin (Fig. 4B) mRNA. I-Plastin mRNA and protein were derived from embryonic lung, skin, foreskin, and gingiva
not detected in the diploid human fibroblast strains KD and from normal individuals and from patients with various
R17 (Fig. 4A, lanes 1 and 2; example shown in Fig. 3B), but genetic diseases such as Huntington's disease, Bloom's
both strains exhibited t-plastin mRNA (Fig. 4B, lanes 1 and syndrome, ataxia telangiectasia, and retinoblastoma. With-
2) and protein (example shown in Fig. 3B). We examined out exception all diploid fibroblast strains exhibited expres-
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L S R N E A L A A L L R D G E T L E E L M K L 207
TTAAGCAGGAATGAAGCCTTGGCTGCTTTACTCCGAGATGGTGAGACTTTGGAGGAACTTATGAAATTG
CTCAGCAGAAATGAAGCTCTGATTGCTCTTTTGAGAGAAGGTGAGAGCCTGGAGGATTTGATGAAACTC
L S R N E A L I A L L R E G E S L E D L M K L
L
S P E E L L L R W A N F H L E N S G W Q K I N 230
TCTCCAGAAGAGCTTCTGCTTAGATGGGCAAACTTTCATTTGGAAAACTCGGGCTGGCAAAAAATTAAC
TCCCCTGAAGAGCTCTTGCTGAGGTGGGCTAATTACCACCTGGAAAATGCAGGCTGCAACAAAATTGGC
S P E E L L L R W A N Y H L E N A G C N K I G
N F S A D I K D S K A Y F H L L N Q I A P K G 253
AACTTTAGTGCTGACATCAAGGATTCCAAAGCCTATTTCCATCTTCTCAATCAAATCGCACCAAAAGGA
AACTTCAGTACTGACATCAAGGACTCAAAAGCTTATTACCACCTGCTTGAGCAGGTGGCTCCAAAAGGA
N F S T D I K D S K A Y Y H L L E Q V A P K G
Q K E G E P R I D I N M S G F N E T D D L K R 276
CAAAAGGAAGGTGAACCACGGATAGATATTAACATGTCAGGTTTCAATGAAACAGATGATTTGAAGAGA
GATGAAGAAGGTGTTCCTGCTGTTGTTATTGACATGTCAGGACTGCGGGAGAAGGATGACATCCAGAGG
D E E G V P A VV I D M S G L R E K D D I Q R
A E S M L Q Q A D K L G C R Q F V T P A D V V 299
GCTGAGAGTATGCTTCAACAAGCAGATAAATTAGGTTGCAGACAGTTTGTTACCCCTGCTGATGTTGTC
GCAGAATGCATGCTGCAGCAGGCGGAGAGGCTGGGCTGCCGGCAGTTTGTCACAGCCACAGATGTTGTC
A E C M L Q Q A E R L G C R Q F V T A T D V V
S G N P K L N L A F V A N L F N K Y P A L T K 322
AGTGGAAACCCCAAACTCAACTTAGCTTTCGTGGCTAACCTGTTTAATAAATACCCAGCACTAACTAAG
CGAGGGAACCCCAAGTTGAACTTGGCTTTTATTGCCAACCTCTTTAACAGATACCCTGCCCTGCACAAA
R G N P K L N L A F I A N L F N R Y P A L H K
P E N Q D I D W T L L E G E T R E E R T F R N 345
CCAGAGAACCAGGATATTGACTGGACTCTATTAGAAGGAGAAACTCGTGAAGAAAGAACCTTCCGTAAC
CCAGAGAACCAGGACATTGACTGGGGGGCTCTTGAAGGTGAGACGAGAGAAGAGCGGACATTTAGGAAC
P E N Q D I D W G A L E G E T R E E R T F R N
W M N S L G V N P H V N H L Y A D L Q D A L V 368
TGGATGAACTCTCTTGGTGTCAATCCTCACGTAAACCATCTCTATGCTGACCTGCAAGATGCCCTGGTA
TGGATGAACTCCCTGGGTGTTAACCCTCGAGTCAATCATTTGTACAGTGACTTATCAGATGCCCTGGTC
W M N S L G V N P R V N H L Y S D L S D A L V
peptide #4-0-V N - L Y - D L
I L Q L Y E R I K V P V D W S K V N K P P Y P 391
ATCTTACAGTTATATGAACGAATTAAAGTTCCTGTTGACTGGAGTAAGGTTAATAAACCTCCATACCCG
ATCTTCCAGCTCTATGAAAAGATCAAAGTTCCTGTTGACTGGAACAGAGTAAACAAACCGCCATACCCC
I F Q L Y E K I K V P V D W N R V N K P P Y P
FIG. 2-Continued
sion of t-plastin in 2-D protein profiles, but not I-plastin. The with 2-D protein gel analysis for these two cell lines (23). The
two transformed fibroblast strains, HuT-12 and HuT-14, tumorigenic strain HuT-14 expressed more I-plastin mRNA
derived after mutagenesis of the KD cell culture (23), exhib- and protein than did the three nontumorigenic HuT strains
ited increasing levels of I-plastin mRNAs (Fig. 4, lanes 3 and (HuT-11, -12, and -13) (Fig. 3C and D; Fig. 4A, lanes 3 and
4, respectively), consistent with our previous observations 4; references 20 and 23). HuT-14T, an even more tumorige-
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K L G A N M K K L E N C N Y A V E L G K H P A 414
AAACTGGGAGCCAACATGAAAAAGCTAGAAAACTGCAACTATGCTGTTGAATTAGGGAAGCATCCTGCT
AAACTGGGAGGCAATATGAAGAAGCTTGAGAATTGTAACTACGCGGTAGAATTGGGGAAGAATCAAGCG
K L G G N M K K L E N C N Y A V E L G K N Q A
K F S L V G I G G Q D L N D G N Q T L T L A L 437
AAATTCTCCCTGGTTGGCATTGGAGGGCAAGACCTGAATGATGGGAACCAAACCCTGACTTTAGCTTTA
AAGTTCTCCCTGGTTGGCATCGGTGGACAAGATCTCAATGAAGGAAACCGCACTCTCACACTGGCCTTG
K F S L V G I G G Q D L N E G N R T L T L A L
F S L V G I G G Q D L N-4peptide #5
V W Q L M R R Y T L N V L E D L G D G Q K A N 460
GTCTGGCAGCTGATGAGAAGATATACCCTCAATGTCCTGGAAGATCTTGGAGATGGTCAGAAAGCCAAT
ATTTGGCAGCTAATGAGAAGGTATACACTGAATATCCTCGAAGAAATTGGTGGTGGCCAGAAGGTCAAT
I W Q L M R R Y T L N I L E E I G G G Q K V N
peptide #6 _ V N
D D I I V N W V N R T L S E A G K S T S I Q S 483
GACGACATCATTGTGAACTGGGTGAACAGAACGTTGAGTGAAGCTGGAAAATCAACTTCCATTCAGAGT
GATGACATTATTGTCAACTGGGTGAATGAAACATTGAGGGAAGCAGAGAAAAGTTCATCCATCTCTAGT
D D I I V N W V N E T L R E A E K S S S I S S
D D I I V NWVN E
F K D K T I S S S L A V V D L I D A I Q P G C 506
TTTAAGGACAAGACGATCAGCTCCAGTTTGGCAGTTGTGGATTTAATTGATGCCATCCAGCCAGGCTGT
TTCAAGGACCCGAAGATTAGTACAAGTCTGCCTGTTCTGGACCTCATCGATGCCATCCAACCAGGTTCC
F K D P K I S T S L P V L D L I D A I Q P G S
peptide #7-0-I S T S L - V L D L I D
I N Y D L V K S G N L T E D D K H N N A K Y A 529
ATAAACTATGACCTTGTGAAGAGTGGCAATCTAACAGAAGATGACAAGCACAATAATGCCAAGTATGCA
ATTAACTATGACCTTCTGAAGACAGAAAATCTGAATGATGATGAGAAACTCAACAATGCAAAATATGCC
I N Y D L L K T E N L N D D E K L N N A K Y A
V S M A R R I G A R V Y A L P E D L V E V K P 552
GTGTCAATGGCTAGAAGAATCGGAGCCAGAGTGTATGCTCTCCCTGAAGACCTTGTGGAAGTAAAGCCC
ATCTCTATGGCCCGAAAAATTGGAGCAAGAGTGTATGCCCTGCCAGAAGACCTGGTTGAAGTGAACCCC
I S M A R K I G A R V Y A L P E D L V E V N P
peptide #8-_ V Y A L P E D L V E V
K M V M T V F A C L M G R G M K R V . 570
AAGATGGTCATGACTGTGTTTGCATGTTTGATGGGCAGGGGAATGAAGAGAGTGTAA
AAAATGGTCATGACCGTGTTTGCCTGCCTCATGGGGAAAGGAATGAAGAGGGTGTGA
K M V M T V F A C L M G K G M K R V
FIG. 2-Continued
nic substrain of HuT-14 (19, 23), was not elevated further in HOS synthesizes a low level of 1-plastin which is barely
I-plastin expression (Fig. 4A, lane 5; reference 23). The detectable in 2-D gels (14), but I-plastin mRNA could not be
human fibrosarcoma cell line (HT1080) and leiomyosarcoma detected in HOS cells by Northern blot analysis (Fig. 4A,
cell line (Sarcoma-2) also expressed I-plastin mRNAs at lane 8). A second osteogenic sarcoma, MG63, and a retino-
levels comparable to those of the HuT strains (Fig. 4A, lanes blastoma tumor cell line, GM1231A, did not exhibit either
6 and 7, respectively). These two cell lines were previously the I-plastin mRNA transcript (Fig. 4A, lanes 13 and 11,
shown to express levels of I-plastin protein comparable to respectively) or the I-plastin polypeptide (data not shown).
that of the HuT strains (14). The osteogenic sarcoma cell line All of the cell strains listed above expressed relatively
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FIG. 3. 2-D gel analysis of cellular proteins and in vitro-translated products. (A) CEM T-lymphoblastoid total cell (ATCC CCL119)
unfractionated proteins stained with silver (30); (B) KD untransformed human fibroblast (22) total cell unfractionated proteins labeled with
[35S]methionine (23); (C) HuT-12 transformed human fibroblasts (22) prepared as in panel B; (D) HuT-14 transformed human fibroblasts (22)
prepared as in panel B; (E) normal human monocyte total unfractionated proteins labeled with [35S]methionine (13); (F) in vitro-translated
[35S]methionine-labeled polypeptides of total poly(A)+ mRNA isolated from HuT-14 transformed fibroblasts (25); (G) in vitro-translated
polypeptides of poly(A)+ mRNA from HuT-14 cells used in panel F and selected by hybridization to the P4 cDNA; (H) in vitro-translated
polypeptides of poly(A)+ mRNA from HuT-14 cells used in panel F and selected by hybridization to the P107 cDNA; (I) in vitro translation
(control) as in panel H, except that no poly(A)+ mRNA was added to the translation reaction; (J) HuT-12 proteins prepared as in panel B;
(K) HuT-12 proteins prepared as in panel B and mixed with in vitro-translated polypeptides prepared as in panel H. Abbreviations: P-A,
,-actin; y-A, y-actin; I-P, I-plastin; t-P, t-plastin; 70 kd, ubiquitous 70-kilodalton polypeptide; SDS, sodium dodecyl sulfate.
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FIG. 4. Northern analysis of plastin expression. Two identical
Northern blots (A and B) were hybridized with 32P-labeled cDNAs
of P107 and P4, respectively. Each blot contains cellular RNAs of
the following cell strains: lane 1, KD, untransformed human fibro-
blasts (22); lane 2, R17, untransformed human fibroblasts provided
by Thomas Hassel, University of North Carolina, Chapel Hill; lane
3, HuT-12, transformed human fibroblasts (22); lane 4, HuT-14,
transformed, tumorigenic human fibroblasts (22); lane 5, HuT-14T,
transformed, tumorigenic human fibroblasts (22); lane 6, HT1080,
human fibrosarcoma (14); lane 7, Sarcoma-2, a cell line derived from
a human leiomyosarcoma and provided by George Milo, Ohio State
University, Columbus; lane 8, HOS, osteosarcoma (14); lane 9,
CEM, human T-cell leukemia (2), ATCC CCL119; lane 10, AG1484
B-lymphoblast strain from the Mutant Human Genetic Cell Repos-
itory, Camden, N.J.; lane 11, GM1231A retinoblastoma strain; lane
12, Molt-4 (20), T-cell leukemia; lane 13, MG63 osteogenic sarcoma,
ATCC CRL1427; lane 14, Rat-2 (19); and lane 15, 3T3 (19).
constant levels of t-plastin mRNA transcripts (Fig. 4B, lanes
1 through 8 and 13) and polypeptides (examples shown in
Fig. 3B and C) except for the retinoblastoma cell line, which
exhibited no detectable plastin mRNA or protein at all (Fig.
4A and B, lane 11; 2-D gel data not shown).
Expression of plastin isoforms in human leukocytes. The
three lymphocyte cell lines, CEM and Molt-4 (both T-cell
leukemias) and AG1484, a transformed B-lymphoblast cell
line, synthesized high levels of I-plastin mRNA (Fig. 4A,
lanes 9, 10, and 12, respectively), but no detectable t-plastin
mRNA (Fig. 4B, lanes 9, 10, and 12, respectively). Leuke-
mic cell lines such as CEM (Fig. 3A) and normal leukocytes
such as peripheral blood leukocytes (13) and cultured mo-
nocytes (Fig. 3E) synthesize the highest levels of I-plastin
protein (13), but no t-plastin protein (Fig. 3A and E). We
examined more than 20 different lymphoblastoid cell lines,
the promyelocytic cell line HL-60 (4), erythrocytes, periph-
eral blood leukocytes from more than 20 individuals, and
subfractions of peripheral blood leukocytes, including T
cells, NK cells, granulocytes, polymorphonuclear leuko-
cytes, and monocytes (13). All cells of hemopoietic origin
except fully differentiated erythrocytes exhibited abundant
synthesis of I-plastin (13) and failed to express t-plastin.
Plastin expression in rodent cells. Finally, we examined
two widely cultured rodent fibroblast strains, Rat-2 (21) and
mouse 3T3 (6, 21, 36), and found that both synthesize
plastins and mRNA corresponding to the human t-plastin
isoform (Fig. 4A, lanes 14 and 15; 2-D gel data not shown).
We also detected mRNA corresponding to human I-plastin
mRNA in mouse B-cell lymphoma cell line M12 (data not
shown). However, we have not been able to identify, by 2-D
gel analysis, I-plastin isoform in mouse lymphocytes (data
not shown) or ras-transformed, herpes simplex virus-trans-
formed, and spontaneously transformed Rat-2 and mouse
3T3 cell lines (21). We have concluded that whereas t-plastin
isoform is well conserved between humans and rodents, the
polypeptide of I-plastin isoform of rodents is too divergent
from that of humans to be recognized by 2-D gel analysis and
that, unlike human I-plastin, the rodent I-plastin does not
appear to be transformation inducible in fibroblasts.
Plastin genomic sequences. We investigated the genomic
representation of both the 1- and the t-plastin isoforms in six
cell strains. The results (Fig. 5) indicate that the 1- and
t-plastin genes are located on separate DNA restriction
fragments in the human genome, and there is no detectable
difference in the restriction digest pattern of the t-plastin
gene among all six human cell strains examined (Fig. 5A).
There is also no detectable difference in the restriction digest
pattern of the I-plastin gene between diploid human fibro-
blasts which do not synthesize I-plastin and transformed
HuT-12 and HuT-14 human fibroblast strains which synthe-
size increasing levels of the I-plastin. The genomic DNA of
peripheral blood leukocytes derived from a healthy human
donor has two Hindlll fragments of 6.5 and 6.0 kb (Fig. SB,
lane 4) instead of the single band of 6.5 kb found in the other
five genomic DNA samples. The peripheral blood leukocytes
of this individual synthesized the variant (polymorphic) form
of the I-plastin (13) in addition to the normal-charge species
of I-plastin. The 6.0-kb fragment, therefore, may be indica-
tive of this variant form of I-plastin. The B-lymphoblast
AG1484 (Fig. SB, lane 5) and the retinoblastoma cell strain
GM1231A (Fig. SB, lane 6) exhibited the same restriction
digest pattern as did the three fibroblast strains.
DISCUSSION
The plastin gene family that we have described encodes a
truly novel set of at least two related, but distinct, proteins
whose expression distinguishes cells of solid tissue from
hemopoietic or leukocyte cells. I-Plastin is a stable protein
that is synthesized constitutively at a very high rate in a
majority of subtypes of peripheral blood leukocytes and is
one of the 10 or 20 most abundant proteins of these normal
leukocyte cells. t-Plastin currently defines two equally abun-
dant polypeptide species in fibroblasts, epithelial, and endo-
thelial cells that appear to have the same molecular weight as
I-plastin, but they are slightly more basic. Our current results
do not establish whether the two t-plastin isoforms differ
from each other because of differing posttranslational mod-
ification or because they are encoded by separate mRNAs or
genes.
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FIG. 5. Genomic representation of plastin genes. Two identical
genomic blots (A and B) were hybridized with 32P-labeled cDNAs of
P4 and P107, respectively. Each blot contains HindIll-digested
genomic DNAs of KD (lane 1), HuT-12 (lane 2), HuT-14 (lane 3),
peripheral blood lymphocytes (lane 4), B-lymphoblast strain
AG1484 (lane 5), and retinoblastoma tumor cell strain GM1231A
(lane 6). Size markers on the right are HindIll fragments of phage
DNA. All human cell strains are described in the legend to Fig. 4.
The divergence of 1- and t-plastin is striking because these
two proteins, though they are clearly related, have diverged
by 17% of their amino acids, with these replacements
scattered almost randomly throughout the 570 amino acid
residues of the plastin sequence. Thirty-three percent of
these amino acid exchanges involve charged amino acid
replacements, with seven short peptide domains exhibiting
significantly greater divergence (residues 1 to 12 [50%],
residues 18 to 30 [58%], residues 224 to 230 [57%], residues
258 to 275 [50%], residues 449 to 459 [50%], residues 487 to
496 [50%], and residues 512 to 523 [58%]).
We scanned three protein sequence data bases (EMBL,
National Institutes of Health, and another one compiled by
Russell Doolittle, University of California, San Diego) for
sequences that were related to plastin and found that no
related protein or peptide sequence has yet been cataloged.
Recently, Matsushima et al. (29) reported the purification
and characterization of a cytosolic 65-kilodalton phospho-
protein in human leukocytes. This protein is clearly I-plastin
because a sequence of 22 amino acids (29) is identical to the
amino acid sequence of I-plastin between residues 533 and
554 (Fig. 2). Their characterization of this protein as a highly
abundant, N-blocked phosphoprotein of all major leukocyte
subpopulations which is not expressed in normal human
fibroblasts or HeLa cells is consistent with our findings
presented here and in other publications (13, 18). Further-
more, their finding that I-plastin is phosphorylated at sefine
residues is consistent with the results of Anderson et al. (4).
Finally, it should be pointed out that the induction of
I-plastin expression in human fibroblasts does not appear to
correlate with the activation of known oncogenes since the
HuT strains, which lack detectable oncogenes that will
transform 3T3 cells (5; unpublished results), and HT1080
cells, which have an activated N-ras oncogene (33), both
423 abundantly express I-plastin. This lack of correlation with
oncogene activation is also characteristic of the actin and
tropomyosin gene families in response to neoplastic trans-
94 formation (6, 9, 16, 21, 28, 38). Plastin, actin, and tropom-
yosin are all highly abundant cellular proteins that have
4 6.7 differentiation-specific isoforms. Their involvement in both
tissue differentiation and neoplastic transformation is con-
sistent with the notion that genes that play critical roles in
oncogenesis are often important constituents in the normal
.44.4 development of tissues.
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